To the full analysis
BrightSpring Health Services stock: growth
BTSGBrightSpring Health Services reported $12.91B in revenue for fiscal 2025, up 14.6% on the prior year, up 24.3% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
26.2%
per year from 2018 to 2025, per share 23.2%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
37.1%
per year from 2018 to 2025, per share 33.9%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2018 | |
|---|---|---|
| Revenue | 18.3% | 26.2% |
| Revenue per share | 14.4% | 23.2% |
| Earnings | 55.7% | no data |
| Earnings per share | 50.9% | no data |
| Free cash flow | 18.2% | 37.1% |
| Free cash flow per share | 14.3% | 33.9% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2018 | $2.54B | −$7.62M | $43.25M |
| 2019 | $4.53B | −$72.38M | $59.69M |
| 2020 | $5.58B | $20.81M | $170.73M |
| 2021 | $6.7B | $49.8M | $210.9M |
| 2022 | $7.72B | −$53.91M | −$74.77M |
| 2023 | $8.83B | −$154.6M | $137.26M |
| 2024 | $11.27B | −$18.06M | −$57.14M |
| 2025 | $12.91B | $190.67M | $394.69M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 22 Aug 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.